Ryght's first LinkedIn Live session discusses how GenAI is transforming clinical development, particularly within Contract Research Organizations (CROs) and trial sponsors.
Tyrone Richardson, Ryght's Chief Commercial Officer, is joined by Megan Liles, Principal Consultant at Liles Clinical Trial Consulting, who brings over 25 years of experience in global project management and innovative technology implementation.
The session explores how GenAI accelerates innovation and addresses long-standing challenges in clinical development. Richardson and Liles delve into the complexities of clinical trials, highlighting technology's role in overcoming common obstacles.